Stimulants and Doping in Sport

Endocrinology and Metabolism Clinics of North America

Volumn 39, Issue 1, 2010, Pages 89-105

  Thevis, Mario ^a   Sigmund, Gerd ^a   Geyer, Hans ^a   Schänzer, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

4 methylhexan 2 amine; Amphetamine; Doping; Ephedrine; Mass spectrometry; Sport

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; CARPHEDON; CENTRAL STIMULANT AGENT; COCAINE; EPHEDRINE; METHAMPHETAMINE; METHOXYPHENAMINE; NITROGEN; NORPSEUDOEPHEDRINE; PELARGONIDIN; PHENETHYLAMINE; PHENYLPROPANOLAMINE; PHOSPHORUS; PSEUDOEPHEDRINE; STRONTIUM 90; STRYCHNINE;

ANALYTIC METHOD; BETA RADIATION; COMPETITION; DOPING; DRUG MISUSE; DRUG SCREENING; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; ENDURANCE; GAS CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MUSCLE STRENGTH; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; REVIEW; SPORTS MEDICINE; TANDEM MASS SPECTROMETRY; URINALYSIS;

AMPHETAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, LIQUID; DOPING IN SPORTS; EPHEDRINE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; PSEUDOEPHEDRINE;

EID: 74049143884     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2009.10.011     Document Type: Review

References (68)

1. Van Dyke C., and Byck R. Cocaine. Sci Am 246 3 (1982) 108-119
2. Wadler G.I., and Hainline B. Drugs and the athlete (1989), F.A. Davis Company, Philadelphia
3. Karas M., and Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem 60 20 (1988) 2299-2301
4. Pelletier P.J., and Caventou J.B. Note sur un Nouvel Alcali. [Note on a new alkaloid]. Annales de chimie et de physique 3 (1818) 323-336 [in French]
5. Rasmussen N. Making the first anti-depressant: amphetamine in American medicine, 1929-1950. J Hist Med Allied Sci 61 (2006) 288-323
6. Raza M. A role for physicians in ethnopharmacology and drug discovery. J Ethnopharmacol 104 3 (2006) 297-301
7. Edeleano L. Ueber einige Derivate der Phenylmethacrylsäure und der Phenylisobuttersäure. [On some derivatives of phenylmethacrylic acid and phenylisobutyric acid]. Berichte der Deutschen Chemischen Gesellschaft 20 1 (1887) 616-622 [in German]
8. Nagai N. Kanyaku maou seibun kenkyuu seiseki (zoku). [Research results on a component of ephedra in Chinese medicine]. Yakugaku zasshi 13 (1893) 901-933 [in Japanese]
9. Freudenmann R.W., Öxler F., and Bernschneider-Reif S. The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents. Addiction 101 9 (2006) 1241-1245
10. Wyndham C.H., Rogers G.G., Benade A.J.S., et al. Physiological effects of the amphetamines during exercise. S Afr Med J 45 (1971) 247-252
11. Laties V.G., and Weiss B. The amphetamine margin in sports. Fed Proc 40 12 (1981 Oct) 2689-2692
12. Ariens E.J. Centrally-active drugs and performance in sports. Schweiz Z Sportmed 13 3 (1965) 77-98
13. Golding L.A., and Barnard J.R. The effect of D-Amphetamine sulfate on physical performance. J Sports Med Phys Fitness 44 (1963) 221-224
14. Karpovich P.V. Effect of amphetamine sulfate on athletic performance. J Am Med Assoc 170 5 (1959) 558-561
15. Magkos F., and Kavouras S.A. Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects. Sports Med 34 13 (2004) 871-889
16. Hodges K., Hancock S., Currell K., et al. Pseudoephedrine enhances performance in 1500-m runners. Med Sci Sports Exerc 38 2 (2006) 329-333
17. Smith G.M., and Beecher H.K. Amphetamine sulfate and athletic performance. I. Objective effects. J Am Med Assoc 170 5 (1959) 542-557
18. Smith G.M., and Beecher H.K. Amphetamine, secobarbital, and athletic performance. III. Quantiative effects on judgment. J Am Med Assoc 172 (1960) 1623-1629
19. Smith G.M., and Beecher H.K. Amphetamine, secobarbital, and athletic performance. II. Subjective evaluations of performance, mood states, and physical states. J Am Med Assoc 172 (1960) 1502-1514
20. WADA. The 2009 prohibited list. Available at: http://www.wada-ama.org/rtecontent/document/2009_Prohibited_List_ENG_Final_20_Sept_08.pdf. Accessed February 1, 2009.
21. George A.J. Central nervous system stimulants. Baillieres Best Pract Res Clin Endocrinol Metab 14 1 (2000) 79-88
22. Docherty J.R. Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA). Br J Pharmacol 154 3 (2008) 606-622
23. Fleckenstein A.E., Volz T.J., Riddle E.L., et al. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47 (2007) 681-698
24. Jones G. Caffeine and other sympathomimetic stimulants: modes of action and effects on sports performance. In: Cooper C.E., and Beneke R. (Eds). Essays in biochemistry (2008), Portland Press, London 109-124
25. Kahlig K.M., Binda F., Khoshbouei H., et al. Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci U S A 102 9 (2005) 3495-3500
26. Delicado E.G., Fideu M.D., Miras-Portugal M.T., et al. Effect of tuamine, heptaminol and two analogues on uptake and release of catecholamines in cultured chromaffin cells. Biochem Pharmacol 40 4 (1990) 821-825
27. WADA. Laboratory statistics. Available at: http://www.wada-ama.org/en/dynamic.ch2?pageCategory.id=594. Accessed February 15, 2008.
28. Deventer K., Van Eenoo P., Baele G., et al. Interpretation of urinary concentrations of pseudoephedrine and its metabolite cathine in relation to doping control. Drug Test Analysis 1 (2009) 209-213
29. Lloyd H.A., Fales H.M., Highet P.F., et al. Separation of alkaloids by gas chromatography. J Am Chem Soc 82 (1960) 3791
30. Parker K.D., Fontan C.R., and Kirk P.L. Separation and identification of some sympathomimetic amines by gas chromatography. Anal Chem 34 10 (1962) 1345-1346
31. Parker K.D., Fontan C.R., and Kirk P.L. Rapid gas chromatographic method for screening of toxicological extracts for alkaloids, barbiturates, sympathomimetic amines, and tranquilizers. Anal Chem 35 3 (1963) 356-359
32. Brochmann-Hanssen E., and Svendsen A.B. Gas chromatography of sympathomimetic amines. J Pharm Sci 51 (1962) 393
33. Brochmann-Hanssen E., and Svendsen A.B. Separation and identification of sympathomimetic amines by gas-liquid chromatography. J Pharm Sci 51 (1962) 938-941
34. Langer S.H., and Pantages P. Peak-shift technique in gas-liquid chromatography: trimethylsilyl ether derivatives of alcohols. Nature 191 (1961) 141-142
35. Donike M. N-Methyl-N-trimethylsilyl-trifluoracetamide, ein neues Silylierungsmittel aus der Reihe der silylierten Amide. [N-Methyl-N-trimethylsilyltrifluoroacetamide, a new silylation agent of the series of silylated amides]. J Chromatogr 42 (1969) 103-104 [in German]
36. Capella P., and Horning E.C. Separation and identification of derivatives of biologic amines by gas-liquid chromatography. Anal Chem 38 (1966) 316-321
37. Donike M. Stickstoffdetektor und Temperaturprogrammierte Gas-Chromatographie, ein Fortschritt für die Routinemäßige Dopingkontrolle. [Nitrogen-specific detector and temperature-programmed gas chromatography, an improvement of routine doping controls]. Sportarzt und Sportmedizin 21 (1970) 27-30 [in German]
38. Donike M. Acylierung mit Bis(Acylamiden); N-Methyl-Bis(Trifluoracetamid) und Bis(Trifluoracetamid), zwei neue Reagenzien zur Trifluoracetylierung. [N-methyl-bis(trifluoroacetamide) and bis(trifluoroacetamide), two new reagants for trifluorocetylation]. J Chromatogr 78 (1973) 273-279 [in German]
39. Donike M., Jaenicke L., Stratmann D., et al. Gas chromatographic detection of nitrogen-containing drugs in aqueous solutions by means of the nitrogen detector. J Chromatogr 52 (1970) 237-250
40. Donike M., and Derenbach J. Die Selektive Derivatisierung Unter Kontrollierten Bedingungen: Ein Weg zum Spurennachweis von Aminen. [Selective derivatization using controlled conditions: A way to detect trace amounts of amines]. Z Anal Chem 279 (1976) 128-129 [in German]
41. Donike M. Temperature programmed gas chromatographic analysis of nitrogen-containing drugs: the reproducibility of retention times (I). Chromatographia 3 (1970) 422-424
42. Donike M., and Stratmann D. Temperaturprogrammierte gas-chromatographische Analyse stickstoffhaltiger Pharmaka: Die Reproduzierbarkeiten der Retentionszeiten und der Mengen bei automatischer Injektion (II) "Die Screeningprozedur für flüchtige Dopingmittel bei den Olympischen Spielen der XX. Olympiade München 1972". [Temperature-programmed gas chromatographic analysis of nitrogen-containing drugs: the reproducibility of retention times using automatic injection (ll). "The screening procedure for volatile doping agents at the Olympic Games of the XX. Olympiade Munich 1972"]. Chromatographia 7 (1974) 182-189 [in German]
43. Schänzer W. Dem Doping keine Chance. [No Chance for doping]. In: Kozel J. (Ed). 25 Jahre Trainerausbildung (1999), Sport & Buch Strauss, Cologne (Germany) 59-94 [in German]
44. Hemmersbach P. History of mass spectrometry at the Olympic games. J Mass Spectrom 43 7 (2008) 839-853
45. Thevis M., and Schänzer W. Examples of doping control analysis by liquid chromatography-tandem mass spectrometry: ephedrines, beta-receptor blocking agents, diuretics, sympathomimetics, and cross-linked hemoglobins. J Chromatogr Sci 43 1 (2005) 22-31
46. Shonle HA, Rohrmann E, Inventors; Eli Lilly & Company, Assignee. Aminoalkanes. US patent US 23503181944, 1944.
47. Marsh D.F., Howard A., and Herring D.A. The comparative pharmacology of the isomeric nitrogen methyl substituted heptylamines. J Pharmacol Exp Ther 103 3 (1951) 325-329
48. Perrenoud L., Saugy M., and Saudan C. Detection in urine of 4-methyl-2-hexaneamine, a doping agent. J Chromatogr B 877 (2009) 3767-3770
49. Thevis M., Sigmund G., Koch A., et al. Determination of tuaminoheptane in doping control urine samples. Eur J Mass Spectrom (Chichester, Eng) 13 3 (2007) 213-221
50. Gohlke R.S., and McLafferty F.W. Mass spectrometric analysis - aliphatic amines. Anal Chem 34 10 (1962) 1281-1287
51. Hammerum S. Distonic radical cations in gaseous and condensed phase. Mass Spectrom Rev 7 2 (1988) 123-202
52. Hammerum S., Norrman K., Solling T.I., et al. Competing simple cleavage reactions: the elimination of alkyl radicals from amine radical cations. J Am Chem Soc 127 17 (2005) 6466-6475
53. Woodruff E.H., Lambooy J.P., and Burt W.E. Physiologically active amines. Secondary and tertiary β-phenylpropylamines and β-phenylisopropylamines. J Am Chem Soc 62 (1940) 922-924
54. Curry J.J., Fuchs J.E., and Leard S.E. Clinical and experimental studies with orthoxine in the treatment of bronchial asthma. J Allergy 20 2 (1949) 104-110
55. Schiller I.W., Lowell F.C., Franklin W., et al. Orthoxine in bronchial asthma; a clinical evaluation. N Engl J Med 241 6 (1949) 231-233
56. Heinzelman R.V. Physiologically active secondary amines. β-(o-Methoxyphenyl)-isopropyl-N-methylamine and related compounds. J Am Chem Soc 75 (1953) 921-925
57. Graham B.E., and Kuizenga M.H. A pharmacologic study of ortho-methoxy-beta-phenylisopropyl methylamine hydrochloride, and thirteen related methoxy analogues. J Pharmacol Exp Ther 94 2 (1948) 150-166
58. Ogden H.D., and Cullick L. Orthoxine in bronchial asthma. Ann Allergy 10 3 (1952) 335-338
59. WADA. The 2008 prohibited list (2008). http://www.wada-ama.org/rtecontent/document/2008_List_En.pdf Accessed November 28, 2007
60. Thevis M., and Schänzer W. Current role of LC-MS(/MS) in doping control. Anal Bioanal Chem 388 (2007) 1351-1358
61. Deventer K., Van Eenoo P., and Delbeke F.T. Screening for amphetamine and amphetamine-type drugs in doping analysis by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 20 5 (2006) 877-882
62. Thevis M., Sigmund G., and Schänzer W. Confirmation of ephedrines - comparison between GC-MS and LC-MS/MS. In: Gotzmann A., Geyer H., Mareck U., et al. (Eds). Recent advances in doping analysis - 21st cologne workshop on doping analysis (2003), Sport & Buch Strauß, Cologne (Germany) 303-307
63. Thevis M., Opfermann G., and Schänzer W. N-methyl-N-trimethylsilyltrifluoroacetamide promoted synthesis and mass spectrometric characterization of deuterated ephedrines. Eur J Mass Spectrom (Chichester, Eng) 10 5 (2004) 673-681
64. WADA. Adverse analytical findings reported by accredited laboratories (2008). Available at: http://www.wada-ama.org/en/dynamic.ch2?pageCategory.id=594 Accessed May 29, 2008
65. Dal Cason T.A. A re-examination of the mono-methoxy positional ring isomers of amphetamine, methamphetamine and phenyl-2-propanone. Forensic Sci Int 119 2 (2001) 168-194
66. Midha K.K., Cooper J.K., McGilveray I.J., et al. Metabolism of methoxyphenamine in man and in monkey. Drug Metab Dispos 4 6 (1976) 568-576
67. Thevis M., Sigmund G., Koch A., et al. Doping control analysis of methoxyphenamine using liquid chromatography-tandem mass spectrometry. Eur J Mass Spectrom 14 (2008) 145-152
68. Geyer H., Parr M.K., Koehler K., et al. Nutritional supplements cross-contaminated and faked with doping substances. J Mass Spectrom 43 7 (2008) 892-902